Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases
Open Access
- 1 June 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (11) , 1538-1544
- https://doi.org/10.1086/420742
Abstract
Aminoglycoside use is limited by ototoxicity and nephrotoxicity. This study compared the incidences of toxicities associated with 2 recommended dosinKeywords
This publication has 24 references indexed in Scilit:
- National Survey of Extended-Interval Aminoglycoside DosingClinical Infectious Diseases, 2000
- Once Daily Aminoglycoside TherapyClinical Pharmacokinetics, 1999
- Familial streptomycin ototoxicity in a South African family: a mitochondrial disorder.Journal of Medical Genetics, 1997
- A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided dosesJournal of Antimicrobial Chemotherapy, 1996
- A Critical Reevaluation of the "Therapeutic Range" of AminoglycosidesClinical Infectious Diseases, 1992
- Determinants of efficacy and toxicity of aminoglycosidesJournal of Antimicrobial Chemotherapy, 1989
- Therapeutic Initiatives for the Avoidance of Aminoglycoside ToxicityThe Journal of Clinical Pharmacology, 1985
- AMINOGLYCOSIDE OTOTOXICITY IN THE HUMANThe Laryngoscope, 1980
- The Nephrotoxicity of Antimicrobial AgentsNew England Journal of Medicine, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976